Uncategorized
Aerie Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced that the Company will participate in the following virtual investor conferences in September. Citi 15th Annual BioPharma Conference Date: Thursday, September 10, 2020 Time: 9:50 a.m